StockData

Aspira Women's Health Inc. (AWHL) stock

AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.22−0.01 (-2.61%)

Close on Oct 19, 2026Market cap $9.91MP/E –Yield –

Aspira Women's Health total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Aspira Women's Health's total debt was $1.71M at Jun 30, 2026. For fiscal 2025 it was $1.77M, down 16.5% from the year before. Over ten years it grew 4.8% a year on average. The highest annual figure on record is $7.00M in fiscal 2011.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.77M-16.5%
FY2024Dec 31, 2024$2.12M-6.4%
FY2023Dec 31, 2023$2.27M-34.9%
FY2022Dec 31, 2022$3.48M-5.8%
FY2021Dec 31, 2021$3.70M-21.9%
FY2020Dec 31, 2020$4.73M+196.7%
FY2019Dec 31, 2019$1.60M+7.7%
FY2018Dec 31, 2018$1.48M-11.1%
FY2017Dec 31, 2017$1.67M-9.9%
FY2016Dec 31, 2016$1.85M+67.2%
FY2014Dec 31, 2014$1.11M0.0%
FY2013Dec 31, 2013$1.11M0.0%
FY2012Dec 31, 2012$1.11M-84.2%
FY2011Dec 31, 2011$7.00M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.71M+10.3%
Q1 FY2026Mar 31, 2026$3.09M+68.5%
Q4 FY2025Dec 31, 2025$1.77M-16.5%
Q3 FY2025Sep 30, 2025$1.33M-14.7%
Q2 FY2025Jun 30, 2025$1.55M-11.5%
Q1 FY2025Mar 31, 2025$1.83M-8.8%
Q4 FY2024Dec 31, 2024$2.12M-6.4%
Q3 FY2024Sep 30, 2024$1.56M-6.5%
Q2 FY2024Jun 30, 2024$1.75M-8.1%
Q1 FY2024Mar 31, 2024$2.01M-36.7%
Q4 FY2023Dec 31, 2023$2.27M-34.9%
Q3 FY2023Sep 30, 2023$1.67M-39.6%
Q2 FY2023Jun 30, 2023$1.90M-38.3%
Q1 FY2023Mar 31, 2023$3.18M-6.1%
Q4 FY2022Dec 31, 2022$3.48M-5.8%
Q3 FY2022Sep 30, 2022$2.77M-6.7%
Q2 FY2022Jun 30, 2022$3.08M-4.4%
Q1 FY2022Mar 31, 2022$3.39M+1.8%
Q4 FY2021Dec 31, 2021$3.70M-21.9%
Q3 FY2021Sep 30, 2021$2.97M+37.8%
Q2 FY2021Jun 30, 2021$3.22M+46.3%
Q1 FY2021Mar 31, 2021$3.33M+167.4%
Q4 FY2020Dec 31, 2020$4.73M+196.7%
Q3 FY2020Sep 30, 2020$2.15M+60.7%
Q2 FY2020Jun 30, 2020$2.20M+58.8%
Q1 FY2020Mar 31, 2020$1.24M-13.2%
Q4 FY2019Dec 31, 2019$1.60M+7.7%
Q3 FY2019Sep 30, 2019$1.34M-12.3%
Q2 FY2019Jun 30, 2019$1.39M-11.9%
Q1 FY2019Mar 31, 2019$1.43M-11.5%
Q4 FY2018Dec 31, 2018$1.48M-11.1%
Q3 FY2018Sep 30, 2018$1.53M-11.1%
Q2 FY2018Jun 30, 2018$1.57M-8.8%
Q1 FY2018Mar 31, 2018$1.62M-8.9%
Q4 FY2017Dec 31, 2017$1.67M-9.9%
Q3 FY2017Sep 30, 2017$1.72M-8.9%
Q2 FY2017Jun 30, 2017$1.73M–
Q1 FY2017Mar 31, 2017$1.78M–
Q4 FY2016Dec 31, 2016$1.85M–
Q3 FY2016Sep 30, 2016$1.89M–

More Aspira Women's Health figures

See a number that looks wrong?